We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.24%
2 Consumer Discretionary 7.38%
3 Financials 6.38%
4 Healthcare 5.93%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHG icon
3501
Philips
PHG
$26.7B
$19K ﹤0.01%
1,204
-9,272
-89% -$133K
QNST icon
3502
QuinStreet
QNST
$1.18B
$19K ﹤0.01%
1,202
-22,418
-95% -$354K
RBOT
3503
DELISTED
Vicarious Surgical
RBOT
$19K ﹤0.01%
275
+84
+44% +$6.53K
RDIB
3504
Reading International Class B
RDIB
$19K ﹤0.01%
907
-6
-0.7% -$122
RSI icon
3505
Rush Street Interactive
RSI
$2.96B
$19K ﹤0.01%
+6,007
New +$23.1K
SAMG icon
3506
Silvercrest Asset Management
SAMG
$79.6M
$19K ﹤0.01%
1,051
+566
+117% +$10.2K
SBFG icon
3507
SB Financial Group
SBFG
$170M
$19K ﹤0.01%
1,380
+852
+161% +$13.5K
SMTI icon
3508
Sanara MedTech
SMTI
$314M
$19K ﹤0.01%
469
-38
-7% -$1.6K
SPNT icon
3509
SiriusPoint
SPNT
$2.76B
$19K ﹤0.01%
2,286
-4,020
-64% -$28.3K
TAP.A icon
3510
Molson Coors Class A
TAP.A
$19K ﹤0.01%
290
+217
+297% +$15.1K
TIL icon
3511
Instil Bio
TIL
$50.1M
$19K ﹤0.01%
1,441
+496
+52% +$7.33K
TNC icon
3512
Tennant Co
TNC
$1.17B
$19K ﹤0.01%
271
-902
-77% -$61.1K
TRAK icon
3513
ReposiTrak
TRAK
$155M
$19K ﹤0.01%
3,070
+1,461
+91% +$8.71K
TRDA icon
3514
Entrada Therapeutics
TRDA
$290M
$19K ﹤0.01%
1,292
+845
+189% +$11.3K
UVSP icon
3515
Univest Financial
UVSP
$1.19B
$19K ﹤0.01%
803
-1,138
-59% -$30.1K
ARQ icon
3516
Arq
ARQ
$102M
$19K ﹤0.01%
9,352
+4,100
+78% +$11.1K
INVX
3517
Innovex International
INVX
$2.18B
$19K ﹤0.01%
653
-1,034
-61% -$30.6K
FNA
3518
DELISTED
Paragon 28, Inc.
FNA
$19K ﹤0.01%
1,138
+571
+101% +$10.2K
DNMR
3519
DELISTED
Danimer Scientific, Inc.
DNMR
$19K ﹤0.01%
134
-120
-47% -$11K
AKLI
3520
DELISTED
Akili Inc
AKLI
$19K ﹤0.01%
12,172
+7,983
+191% +$12.5K
NGM
3521
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$19K ﹤0.01%
4,771
+1,719
+56% +$7.95K
ALYA
3522
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
$19K ﹤0.01%
9,409
-6,371
-40% -$11.6K
BRDS
3523
DELISTED
Bird Global, Inc.
BRDS
$19K ﹤0.01%
2,654
+368
+16% +$1.91K
CS
3524
DELISTED
Credit Suisse Group
CS
$19K ﹤0.01%
20,746
+6,484
+45% +$18.1K
ISDX
3525
DELISTED
Invesco Exchange-Traded Self-Indexed Fund Trust Invesco RAFI Strategic Developed ex-US ETF
ISDX
$19K ﹤0.01%
726
+380
+110% +$10.8K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.